On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Bariatric Surgery Benefits Men Too
Most followup studies of patients who had bariatric surgery focus on young women. A Seattle study of mostly male patients getting care at Veterans Affairs bariatric centers showed these patients, though older and with more risk factors than the female patients in many other studies, had lower death rates than obese patients who did not get the surgery.
Link between Pigment Production and Mitochondrial Function in Melanoma
New research published in the January 2015 issue of FASEB Journal highlighted a direct correlation between mitochondrial function alterations and the production of melanin in cancerous skin cells. Researchers found that as melanoma cells produce increased melanin pigment, the mitochondria retaliates by matching production levels of reactive oxygen species.
Cholera Bacterium: Silent Murderers?
A group of scientists have recently discovered the method to cholera bacterium's madness: horizontal gene transfer‑stabbing and killing other bacteria to absorb their DNA. The disease, which is associated with acute watery diarrhea, is often caused by Vibrio cholera (V. cholerae) infection within the small intestine.
Ebola Blood Filter Trial Cleared
Aethlon Medical, a San Diego, CA device manufacturer has FDA approval for new clinical protocol to test a blood filtering device for use in treating Ebola patients. The device, called the Hemopurifier can be connected to a dialysis machine for one-use filtering of the blood to remove virus particles. The Jan. 2 FDA approval clears the way for a planned US clinical trial of the J device. The company has an on-going trial to test its use in reducing the viral load in patients infected with Hepatitis C. The company's hope is that the device could be used to treat patients with many life-threatening viral infections, including HIV.
Many Gout Patients in England Not Receiving Needed Treatments
For patients living with gout, the pain and discomfort associated with the condition can be relieved by widely available medications. According to a recent study, many patients in England are not getting the treatment they need to help them live symptom-free on a regular basis.
Study: Whole Grain Consumption Lowers Death Risk
Just weeks after JAMA published a National Institutes of Health study refuting the idea that there are "good carbs" and "bad carbs' a new study in the journal finds eating whole grains is associated with lower overall mortality and death from heart disease
Healthy Resolutions Show Benefits Long After New Year's Eve
With a new year comes New Year's resolutions, many of which involve getting healthy in the year ahead. A recent study has shown that by keeping those resolutions people can not only lose the weight they want but also avoid other health issues like diabetes.
Hysterectomy's Environmental Footprint
January 2nd 2015Many health care organizations have started to lessen their environmental impact slowly by tackling small problems and making manageable changes. A multidisciplinary team of researchers from across the US carved out one surgical procedure to determine environmental impact. Their assessment of abdominal, vaginal, laparoscopic, and robotic hysterectomy appears ahead of print in the journal Environmental Science and Technology.
Tracheotomy: When the Patient Sues
January 2nd 2015In many medical fields, malpractice has driven changes in the way physicians practice medicine. In the surgical field, tracheotomies are often crucial, but are associated with a high risk of morbidity and mortality. A quick look at the results when one enters "tracheotomy" and "lawsuit" into any search engine shows that patients, dissatisfied with myriad aspects of breathing through a tube, often sue after this procedure.
Contact Force Sensing Increases Atrial Fibrillation Treatment for Some
New research indicates that contact force sensing technology increases the effectiveness of catheter ablations among patients with paroxysmal atrial fibrillation (AF) - but not among patients with non-paroxysmal AF.
Case Study: an Obese Toddler with Mutant Leptin
The role of the hormone leptin in promoting obesity is a growing area of research. In a case study from Germany reported in the New England Journal of Medicine, Martin Wabitsch, MD, PhD and colleagues report success in treating an obese toddler with recombinant human leptin.
Chikungunya virus could become the infectious disease of the hour-not because of any new cases in the US, but because actress Lindsay Lohan says she has it.Lohan has been tweeting about contracting the febrile, mosquito-borne illness during a vacation in French Polynesia.There have been locally transmitted cases in the US.
2014 Shows Progress in Treatment of Gastrointestinal Issues
December 31st 2014From inflammatory bowel disease to Crohn's disease and everywhere in the gastrointestinal system in between 2014 was a big year for medical breakthroughs and potential future treatments. Here is a look at the top 10 stories.
Search for Diabetes Cure Highlights Top Stories of 2014
December 30th 2014Obesity and physical activity have become a focus of the healthcare community in the recent past and that was no exception in 2014. Over the past 12 months we have highlighted advancements in the treatment, diagnosis and impact of diabetes on our daily lives. Here is a look at the top 10 stories from the year.
Express Scripts Pens Exclusive Deal for Abbvie Hepatitis C Drug
December 30th 2014Express Scripts has dropped Solvaldi, Harvoni, and Olysio in favor of an exclusive deal with the drug maker AbbVie Inc. to prescribe its newly approved hepatitis C drug called Viekira Pak, according to a statement from the prescription drug-benefits management company.
MS Stem Cell Treatments Show 3-Year Benefit
Treating patients with relapsing-remitting multiple sclerosis (RRMS) with autologous hematopoietic cell transplantation (HCT) has worked for most patients based on an interim report 3 years into a study. But the therapy has risks that critics say outweigh the benefits.